CSGALNACT2 antibody
Principal name
CSGALNACT2 antibody
Alternative names for CSGALNACT2 antibody
CHGN2, GALNACT2, Beta4GalNAcT-2, GalNAcT-2, Chondroitin sulfate N-acetylgalactosaminyltransferase 2, Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2
Ncbi ID
9606, NP_061060, NP_061060.3, NM_018590, NP_084441.3, BC060169, NM_030165
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of CSGALNACT2 antibody
- Kit Component:
- - KN303894G1, Csgalnact2 gRNA vector 1 in pCas-Guide vector
- KN303894G2, Csgalnact2 gRNA vector 2 in pCas-Guide vector
- KN303894D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Western blot analysis of CSGALNACT2 Antibody (Center) (AP17956PU-N) in 293 cell line lysates (35ug/lane). CSGALNACT2 (arrow) was detected using the purified Pab.

Western Blot analysis of GALNACT-2 expression in transfected 293T cell line (H00055454-T02) by GALNACT-2 MaxPab polyclonal antibody.Lane 1: GALNACT-2 transfected lysate(62.60 KDa).Lane 2: Non-transfected lysate.

Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using CSGALNACT2 antibody.The picture on the right is treated with the synthesized peptide.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA315587 | CSGALNACT2 antibody |
||||||
| Rabbit polyclonal CSGALNACT2 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA349623 | CSGALNACT2 antibody |
||||||
| Rabbit Polyclonal Anti-CSGALNACT2 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP17956PU-N | CSGALNACT2 antibody |
||||||
![]() |
Rabbit | Hu | WB |
0.4 ml /
€415.00
|
|||
| OriGene Technologies GmbH | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY412995 | CSGALNACT2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR215751L1V | Lenti ORF particles, Csgalnact2 (Myc-DDK-tagged) - Mouse chondroitin sulfate N-acetylgalactosaminyltransferase 2 (Csgalnact2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| MR204025L2V | Lenti ORF particles, Galnact2 (GFP-tagged) - Mouse chondroitin sulfate GalNAcT-2 (cDNA clone MGC:63447 IMAGE:6826555), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR204025L1V | Lenti ORF particles, Galnact2 (Myc-DDK-tagged) - Mouse chondroitin sulfate GalNAcT-2 (cDNA clone MGC:63447 IMAGE:6826555), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||





